Funding
← Back to your selection

Blue Owl Healthcare Opportunities

Activity from announced rounds

Activity in this selectionomers-ventures-009db13b
Rounds participated in
2
Confirmed lead rounds
1
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$350M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Ambrosia Biosciences

Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders.

$100MSeries B
Lead
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B
Role not disclosed